Archives

  • More than 150 countries engaged in COVID-19 vaccine global access facility

    Seventy-five countries have submitted expressions of interest to protect their populations and those of other nations through joining the COVAX

    Read More
  • Cipla Receives Final Approval for Generic Version of Shire’s Firazyr®

    Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as (“Cipla”) today announced that it has received final approval

    Read More
  • US FDA approves Janssen’s Tremfya for adult patients with active psoriatic arthritis

    The U.S. Food and Drug Administration (FDA) approved Janssen Pharmaceutical‘s Tremfya as a treatment for active psoriatic arthritis. The approval marks the first time

    Read More
  • FICCI-Swasth partnership to drive rapid healthcare transformation

    Federation of Indian Chambers of Commerce and Industry (FICCI) has partnered exclusively with Swasth, a not-for-profit consortium of healthcare players

    Read More
  • Biophore India gets DCGI nod to manufacture COVID-19 drug Favipiravir

    Biophore India Pharmaceuticals, a city-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir,

    Read More

Archive

Offers
error: Content is protected !!